NO20012634L - Nye kreftbehandlinger - Google Patents

Nye kreftbehandlinger

Info

Publication number: NO20012634L
Authority: NO; Norway
Prior art keywords: derivatives; cells; cancer treatments; whole; portions
Prior art date: 1998-12-10

Application number

NO20012634A

Other languages

English (en)

Other versions

NO327044B1 (no

NO20012634D0 (no

Inventor

Angus George Dalgleish

Peter Michael Smith

Andrew Derek Sutton

Anthony Ian Walker

Original Assignee

Onyvax Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-10

Filing date

2001-05-29

Publication date

2001-08-08

2001-05-29 Application filed by Onyvax Ltd filed Critical Onyvax Ltd

2001-05-29 Publication of NO20012634D0 publication Critical patent/NO20012634D0/no

2001-08-08 Publication of NO20012634L publication Critical patent/NO20012634L/no

2009-04-06 Publication of NO327044B1 publication Critical patent/NO327044B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/884—Vaccine for a specifically defined cancer prostate

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Microbiology (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Cell Biology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Developmental Biology & Embryology (AREA)
Virology (AREA)
Zoology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

NO20012634A 1998-12-10 2001-05-29 Allogent immunterapeutisk middel, immunogen sammensetning, vaksinesammensetning og anvendelser derav, i forbindelse med behandling av prostatakreft NO327044B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9827104.2A GB9827104D0 (en)	1998-12-10	1998-12-10	New cancer treatments
PCT/GB1999/004129 WO2000033869A2 (en)	1998-12-10	1999-12-09	Use of human prostrate cell lines in cancer treatment

Publications (3)

Publication Number	Publication Date
NO20012634D0 NO20012634D0 (no)	2001-05-29
NO20012634L true NO20012634L (no)	2001-08-08
NO327044B1 NO327044B1 (no)	2009-04-06

Family

ID=10843926

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20012634A NO327044B1 (no)	1998-12-10	2001-05-29	Allogent immunterapeutisk middel, immunogen sammensetning, vaksinesammensetning og anvendelser derav, i forbindelse med behandling av prostatakreft

Country Status (19)

Country	Link
US (3)	US6972128B1 (no)
EP (1)	EP1137422B1 (no)
JP (2)	JP4949554B2 (no)
KR (1)	KR20010090874A (no)
AT (1)	ATE304365T1 (no)
AU (1)	AU763485B2 (no)
CA (1)	CA2354045C (no)
CZ (1)	CZ300499B6 (no)
DE (1)	DE69927286T2 (no)
ES (1)	ES2249046T3 (no)
GB (1)	GB9827104D0 (no)
HU (1)	HUP0104568A3 (no)
IL (2)	IL143296A0 (no)
MX (1)	MXPA01005816A (no)
NO (1)	NO327044B1 (no)
NZ (1)	NZ512004A (no)
PL (1)	PL201016B1 (no)
WO (1)	WO2000033869A2 (no)
ZA (1)	ZA200104164B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9827104D0 (en) *	1998-12-10	1999-02-03	Onyvax Ltd	New cancer treatments
GB9827103D0 (en) *	1998-12-10	1999-02-03	Onyvax Ltd	New cancer treatments
WO2000071156A2 (en) *	1999-05-21	2000-11-30	Onyvax Limited	New vaccine formulations-3
EP1272617B1 (en) *	2000-04-01	2011-04-27	Onyvax Limited	Prostate cell lines and their use
US6667479B2 (en) *	2001-06-01	2003-12-23	Raytheon Company	Advanced high speed, multi-level uncooled bolometer and method for fabricating same
US20050019336A1 (en) *	2003-07-23	2005-01-27	Dalgleish Angus George	Human prostate cell lines in cancer treatment
BRPI0414014A (pt) *	2003-08-26	2006-10-24	Becton Dickinson Co	métodos para distribuição intradérmica de agentes terapêuticos
KR101323540B1 (ko)	2007-02-07	2013-10-29	사이단호진한다이비세이부쯔뵤우겐큐우카이	암의 치료제
WO2009066462A1 (ja) *	2007-11-20	2009-05-28	Nec Corporation	細胞傷害性ｔ細胞の誘導方法、細胞傷害性ｔ細胞の誘導剤、およびそれを用いた医薬組成物およびワクチン
AU2009200767A1 (en) *	2008-03-10	2009-09-24	Aristocrat Technologies Australia Pty Limited	A gaming system and a method of gaming
EP2376089B1 (en)	2008-11-17	2018-03-14	The Regents of the University of Michigan	Cancer vaccine compositions and methods of using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE322286T1 (de) *	1991-10-04	2006-04-15	Whitehead Biomedical Inst	Regulierung der systemischen immunantworten mittels zytokinen und antigenen
JPH05246889A (ja) *	1992-03-05	1993-09-24	Seitai Chiyousetsu Kenkyusho:Kk	制癌方法および制癌剤
WO1995029704A1 (en) *	1994-04-28	1995-11-09	Scott Freeman	Cell lines obtained by in vivo migration and by fusion with autoimmune cells
DE69636514D1 (de) *	1995-03-17	2006-10-19	Univ California	Methode zur tumorbehandlung mit alloaktivierten humanen lymphozyen
US5788963A (en) *	1995-07-31	1998-08-04	Pacific Northwest Cancer Foundation	Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
EP0869803B1 (en) *	1995-12-28	2003-04-16	The Johns Hopkins University School Of Medicine	Allogeneic paracrine cytokine tumor vaccines
EP0877798B1 (en) *	1996-02-02	2003-05-07	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer
GB9620350D0 (en) *	1996-09-30	1996-11-13	Maudsley David J	Cancer vaccine
US6207805B1 (en) *	1997-07-18	2001-03-27	University Of Iowa Research Foundation	Prostate cell surface antigen-specific antibodies
GB9827104D0 (en) *	1998-12-10	1999-02-03	Onyvax Ltd	New cancer treatments

1998
- 1998-12-10 GB GBGB9827104.2A patent/GB9827104D0/en not_active Ceased
1999
- 1999-12-09 MX MXPA01005816A patent/MXPA01005816A/es active IP Right Grant
- 1999-12-09 IL IL14329699A patent/IL143296A0/xx active IP Right Grant
- 1999-12-09 EP EP99959542A patent/EP1137422B1/en not_active Expired - Lifetime
- 1999-12-09 US US09/857,691 patent/US6972128B1/en not_active Expired - Lifetime
- 1999-12-09 JP JP2000586359A patent/JP4949554B2/ja not_active Expired - Fee Related
- 1999-12-09 CZ CZ20012032A patent/CZ300499B6/cs not_active IP Right Cessation
- 1999-12-09 KR KR1020017007096A patent/KR20010090874A/ko not_active Ceased
- 1999-12-09 DE DE69927286T patent/DE69927286T2/de not_active Expired - Lifetime
- 1999-12-09 PL PL348828A patent/PL201016B1/pl not_active IP Right Cessation
- 1999-12-09 AU AU16683/00A patent/AU763485B2/en not_active Ceased
- 1999-12-09 WO PCT/GB1999/004129 patent/WO2000033869A2/en not_active Ceased
- 1999-12-09 ES ES99959542T patent/ES2249046T3/es not_active Expired - Lifetime
- 1999-12-09 CA CA2354045A patent/CA2354045C/en not_active Expired - Fee Related
- 1999-12-09 HU HU0104568A patent/HUP0104568A3/hu unknown
- 1999-12-09 NZ NZ512004A patent/NZ512004A/en unknown
- 1999-12-09 AT AT99959542T patent/ATE304365T1/de not_active IP Right Cessation
2001
- 2001-05-22 ZA ZA200104164A patent/ZA200104164B/en unknown
- 2001-05-22 IL IL143296A patent/IL143296A/en not_active IP Right Cessation
- 2001-05-29 NO NO20012634A patent/NO327044B1/no not_active IP Right Cessation
2005
- 2005-07-12 US US11/178,415 patent/US8034360B2/en not_active Expired - Fee Related
2011
- 2011-10-07 JP JP2011223318A patent/JP2012021028A/ja active Pending
- 2011-10-11 US US13/270,820 patent/US20120164099A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO327044B1 (no)	2009-04-06
IL143296A (en)	2006-06-11
PL348828A1 (en)	2002-06-17
AU1668300A (en)	2000-06-26
HUP0104568A2 (hu)	2002-03-28
DE69927286T2 (de)	2006-06-29
ES2249046T3 (es)	2006-03-16
CZ300499B6 (cs)	2009-06-03
NO20012634D0 (no)	2001-05-29
CA2354045C (en)	2012-02-21
HUP0104568A3 (en)	2004-05-28
PL201016B1 (pl)	2009-02-27
WO2000033869A2 (en)	2000-06-15
IL143296A0 (en)	2002-04-21
CA2354045A1 (en)	2000-06-15
DE69927286D1 (de)	2005-10-20
EP1137422B1 (en)	2005-09-14
AU763485B2 (en)	2003-07-24
US6972128B1 (en)	2005-12-06
WO2000033869A3 (en)	2000-10-12
US20050249756A1 (en)	2005-11-10
MXPA01005816A (es)	2002-03-27
US20120164099A1 (en)	2012-06-28
NZ512004A (en)	2003-08-29
CZ20012032A3 (cs)	2001-10-17
EP1137422A2 (en)	2001-10-04
KR20010090874A (ko)	2001-10-19
US8034360B2 (en)	2011-10-11
ZA200104164B (en)	2002-01-24
ATE304365T1 (de)	2005-09-15
GB9827104D0 (en)	1999-02-03
JP2012021028A (ja)	2012-02-02
JP2002531520A (ja)	2002-09-24
JP4949554B2 (ja)	2012-06-13

Similar Documents

Publication	Publication Date	Title
NO20021830D0 (no)	2002-04-18	Sammensetninger egnet til å forhindre og behandle forkjölelse og influensaliknende symptomer samt fremgangsmåter vedfremstilling derav
MY155218A (en)	2015-09-30	Small molecules useful in the treatment of inflammatory disease
BR0212924A (pt)	2005-01-04	Inibidores de glicogênio sintase quinase-3 (gsk-3) para o tratamento de glaucoma
BR0107705A (pt)	2002-11-19	Uso de uma alìquota de sangue modificado em um paciente para tratamento de falência cardìaca congestiva
ES2191152T3 (es)	2003-09-01	Terapia combinada para el tratamiento de psicosis.
NO20061912L (no)	2006-06-02	Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system
NO20012634D0 (no)	2001-05-29	Nye kreftbehandlinger
DE60327438D1 (de)	2009-06-10	Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen
BR0208675A (pt)	2004-08-03	Combinação imunoterapêutica para a imunoterapaia de tumores que superexpressam gangliosìdeos, uso da mesma e método para controlar o crescimento e/ou a proliferação de células tumorais que superexpressam gangliosìdeos
MXPA01010982A (es)	2003-07-21	Uso de phyllanthus para la estimulacion dirigida al objetivo del sistema inmune.
CY1105818T1 (el)	2011-02-02	Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
WO2006047716A3 (en)	2007-05-31	Use of diindolylmethane-related indoles and growth factor receptor inhibitors for the treatment of human cytomegalovirus associated disease
MY122216A (en)	2006-03-31	New vaccine and method of use
NO984760L (no)	1998-10-12	Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
IS5570A (is)	2000-07-21	Meðhöndlun á risaeitlingasarkmeini með tálmum viðeitilfrumueiturslóðinni
BR0307085A (pt)	2004-12-07	Terapia combinada para o tratamento de infecções bacterianas
WO2002058535A3 (en)	2003-02-06	Use of combretastatin a4 and its prodrugs as an immune enhancing therapy
DE69723580D1 (de)	2003-08-21	Impfstoff gegen metastasierenden kolorektalkrebs.
AU3439799A (en)	1999-11-23	Immunization against and treatment for infection by (h.pylori)
BR0111785A (pt)	2003-05-20	Composições e métodos para tratamento de candidìase
DE60128801D1 (de)	2007-07-19	Isoflavonen gegen strahlungsinduzierte Mortalität
CA3244259A1 (en)	2023-08-31	Compositions and methods for modulating the immune system
MXPA05004121A (es)	2006-02-17	Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
CY1109771T1 (el)	2014-09-10	Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες
BR0015121A (pt)	2002-07-02	Composição farmacêutica utilizável para o tratamento de inflamação em humanos, e, método de tratamento de inflamação

Legal Events

Date	Code	Title	Description
2010-07-19	MM1K	Lapsed by not paying the annual fees